Clinical Trial Update: Study to Evaluate the Effectiveness of SGB in Preventing Post-op Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating SGB to prevent postoperative atrial fibrillation has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• SGB

Snippet

Sponsor: Christopher Connors, MD | Conditions: Atrial Fibrillation | Phase 4 | Status: WITHDRAWN